CMS Announces 2018 Medicare Advantage and Drug Program Rates
In an ongoing effort to strengthen the Medicare Advantage and the Prescription Drug Program by supporting flexibility, efficiency, and innovation, the Center Medicare & Medicaid Services (CMS) released final updates to the Medicare Advantage and Part D Prescription Drug Program for 2018.
The final policies are similar to the proposal released in February’s 2018 Advance Notice and Draft Call Letter. There are several changes, however, in response to feedback received during the public comment period.
According to CMS’ April 3 press release, some of the policies in the rate announcement will:
- Provide flexibility and incentives to encourage organizations to develop new plan offerings
- Provide incentives for plans to submit complete encounter data
- Modify the phase-in of the use of encounter data
- Use encounter data for 15 percent of the risk adjustment payment to Medicare Advantage plans
- Help combat overuse of opioids by encouraging safeguards before an opioid prescription is dispensed at the pharmacy
- Employ best practices and the most appropriate care management interventions for enrollees using high dosage opioids
The “Year-to-Year Percentage Change in Payment” is:
|Effective Growth Rate||2.8%||2.7%|
|Change in Star Ratings||-0.4%||-0.4%|
|MA coding intensity adjustment||-0.25%||-0.25%|
|Expected Average Change in Revenue||0.25%||0.45%|
|Expected Average Change in Revenue
with Coding trend
For more information, read the Fact Sheet “2018 Medicare Advantage and Part D Rate Announcement and Call Letter, and Request for Information” on the CMS website.
CMS is accepting comments on the Request for Information until April 24 at PartCDcomments@cms.hhs.gov. Please include “2017 Transformation Ideas” in the subject line.